Risk of Viral Hepatitis among Military Personnel Assigned to US Navy Ships

A prevalence study of 2072 male US shipboard military personnel scheduled for deployment to South America/West Africa and the Mediterranean was conducted to determine whether serologic evidence of prior hepatitis A, B, or C infection is associated with exposure in foreign countries. There were 210 s...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 165; no. 4; pp. 716 - 719
Main Authors: Hawkins, Richard E., Malone, John D., Cloninger, Lee A., Rozmajzl, Patrick J., Lewis, Drew, Butler, James, Cross, Eleanor, Gray, Stephanie, Hyams, Kenneth C.
Format: Journal Article
Language:English
Published: Chicago, IL The University of Chicago Press 01-04-1992
University of Chicago Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A prevalence study of 2072 male US shipboard military personnel scheduled for deployment to South America/West Africa and the Mediterranean was conducted to determine whether serologic evidence of prior hepatitis A, B, or C infection is associated with exposure in foreign countries. There were 210 subjects (10.1%) who had antibodies to hepatitis A virus (anti-HAV), 76 (3.7%) to hepatitis B core antigen (anti-HBc), and 9 (0.4%) to hepatitis C virus (anti-HCV). By multivariate analysis, anti-HAV seropositivity was independently associated with age, nonwhite racial/ethnic groups, birth outside of the United States, and prior Caribbean deployment for <1 year. Anti-HBc seropositivity was independently associated with black and Filipino race/ ethnicity, foreign birth, a history of a sexually transmitted disease, South Pacific/Indian Ocean deployment <12 months), and South Pacific or Mediterranean duty for (>1 year). No geographic risk factors were associated with anti-HCV positivity. These data indicate that military personnel deployed outside the United States are at increased risk ofviral hepatitis infection and should be considered for vaccination.
Bibliography:ark:/67375/HXZ-QJQX5MKV-L
Reprints or correspondence: Dr. Richard E. Hawkins. Infectious Disease Division, National Naval Medical Center, Bethesda. MD 20889-1000.
istex:BB14990EE47512F00A2A4081FEEA1B0C3D230BA3
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/165.4.716